Generics 153

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Deflazacort manufacturers

153 products found

Filters

153 products found

deflazacort

Tablets 6 mg, 30 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Kosovo , Portugal , Vietnam , Sudan
Registered in
Portugal
Available for
Licensing with supply, Distribution only
Manufacturer #16024

A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, Africa, Middle East, CIS, North America, LATAM, and Asia for 50+ years. Key production lines are RX products, OTC, cosmetics, food supplements, and veterinary products. They are produced in GMP-compliant manufacture. The main dosage forms are liquid, solid, and semi-solid. The main therapeutic areas are dermatology, metabolic diseases, and respiratory. The company possesses a branch in Africa.

Manufacturer usually replies in 10 days

deflazacort

Tablets 6 mg, 30 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Sugar free, Alcohol free
Manufacturer #1969
A pharmaceutical manufacturer based in the EU that has been active in 20+ countries selling its products in Europe, the Middle East, LATAM, Africa, and Asia for 80+ years. The company's production lines are GMP-compliant. Main therapeutic areas include the cardiovascular system, CNS, and respiratory system. Main dosage forms include oral solid, oral liquid, and semi-solid forms.

Manufacturer usually replies in 22 days

deflazacort

Oral suspension 22,75 / mL

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #1858

Manufacturer usually replies in 2 days

deflazacort

Tablets 30mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #1858

Manufacturer usually replies in 2 days

deflazacort

Tablets 6mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #1858

Manufacturer usually replies in 2 days

deflazacort

Oral suspension 22.75 mg / ml

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #17629

Manufacturer usually replies in 13 days

deflazacort

Tablets 6 mg, 18 mg, 30 mg, 36 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #17629

Manufacturer usually replies in 13 days

deflazacort

Tablets 6 mg, 30 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, India
Registered in
India
Available for
Licensing with supply, Distribution only, Technology transfer
MAs for sale
India
Manufacturer #22627

Manufacturer usually replies in 4 days

deflazacort

Tablets 6 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Manufacturer #18850

Manufacturer usually replies in 2 days

deflazacort

Tablets 6 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Manufacturer #18850

Manufacturer usually replies in 2 days

deflazacort

Tablets 6 mg, 30 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
GMP approvals
Egypt
Manufacturer #21954

Manufacturer usually replies in 1 days

deflazacort

Tablets 6 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
India
Manufacturer #21247

Manufacturer usually replies in 3 days

deflazacort

Tablets 6 mg, 30 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21177

Manufacturer usually replies in 12 days

deflazacort

Tablets 6 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20477

Manufacturer usually replies in 3 days

deflazacort

Tablets 6 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20428

Manufacturer usually replies in 4 days

deflazacort

Tablets 1 mg, 6 mg, 30 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20299

Manufacturer usually replies in 1 days

deflazacort

Tablets 6 mg, 30 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20301

Manufacturer usually replies in 2 days

deflazacort

Tablets 1 mg, 6 mg, 12 mg, 30 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20306

Manufacturer usually replies in 1 days

deflazacort

Tablets 6 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20221

Manufacturer usually replies in 5 days

deflazacort

Tablets 6 mg, 12 mg, 30 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20162

Manufacturer usually replies in 3 days

Want to view all 153 products? Create your free account today!

Deflazacort is used as an immunosuppressant and also as an anti-inflammatory medication. It is popular in the United Kingdom with its trade name used by the manufacturers and distributors, Calcort. This drug was patented in the year 1965. Medical use of this drug began in 1985. Also referred to as Emflaza by the manufacturers, this corticosteroid is useful for managing the symptoms of Duchenne Muscular Dystrophy [DMD]. The leading Deflazacort manufacturer is Marathon Pharmaceuticals. This drug was approved by the FDA in the year 2017.
Duchenne Muscular Dystrophy results because of the mutations in the dystrophin gene. This gene is crucial for muscle function. The condition can result in cardiovascular disability, progressive breathing, and serious muscle weakness. The disease manifests by resulting in extreme muscle fatigue followed by the loss of ability to walk by the age of 7.
Deflazacort assists in delaying the onset of complications in muscles. This further prolongs the lives of children who have been diagnosed with the condition. The medication can lower the harmful effects on bone health in comparison to other steroid medications being offered by the trusted pharma manufacturers.
Deflazacort cannot be considered to be a cure for muscular dystrophy. However, it does strengthen the muscles and also slows down the progression of disability. The NHS prescription price for 6mg of this drug is £9.00. The wholesale cost may be a little lesser than this. Apart from being beneficial to muscles, this drug can also help with conditions such as Asthma, Crohn’s Disease, Lymphatic Leukemia, multiple myeloma, Pemphigus, Sarcoidosis, Ulcerative colitis, juvenile chronic arthritis and many more.
The FDA approved a fast track status in January 2015 to Marathon Pharmaceuticals for treatment of Duchenne Muscular Dystrophy which is a rare and fatal disease. The CEO of this pharmaceutical manufacturing company made an announcement about the launch of this drug amidst controversy surrounding the steep price of the drug. The price at which the drug was being launched was 70 times more than it would cost in other nations overseas.
The conditions have now changed as far as the wholesale price of this drug is concerned. As the drug has been approved in several nations, the Deflazacort manufacturers are now offering it at lower rates. For instance, in Canada, the drug can be purchased for $1 per tablet. The Deflazacort suppliers are offering this drug under the trade name after the rights were purchased by PTC Therapeutics Inc. from Marathon Pharmaceuticals. In the United Kingdom, Deflazacort suppliers use the trade name Calcort. In Brazil, the distributors use the trade name Cortax or Defcort.
Most companies argue the price for this drug is exorbitant. Initially, the price was indeed more. However, the CEO of the company during the launch of the drug in the US stated that the price tag was due to the evaluation of future dynamics of the market. The net price of Deflazacort has now reduced. Though controlling the price in the future is going to be a challenge for the companies holding the license to manufacture this drug.
If you are a distributor, then you can make good use of the opportunity available and secure a great deal for Deflazacort from the leading manufacturers on Pipelinepharma. You can achieve the best cost/benefit ratio by bypassing lengthy sourcing, negotiation, and ordering process.

We use cookies to offer you a better user experience, provide special features or analyze anonymous traffic data. Find out more about how we use cookies .